One scientist may have cracked the code to curing Alzheimer’s and Parkinson’s—using a single molecular switch.

Scientific research has traditionally been a slow and careful process. Scientists spend years testing ideas and doing ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Microsoft Scientific Discovery is an AI-powered research-focused platform designed for scientists, research institutions, and ...

Colorado BioScience Association (CBSA) commends the Colorado Office of Economic Development and International Trade (OEDIT) for awarding $3.135 Million in Commercialization Infrastructure grants under ...

Collaboration combines Nuclera’s eProtein Discovery System with Cytiva’s Biacore SPR system.

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

The collaboration will work with Nuclera’s eProtein TM Discovery System with Cytiva’s ... to these proteins and understanding how they interact with drug candidates is essential for drug development.

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan ...